A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

Status:
Completed

Trial end date:
2003-02-01

Target enrollment:

Participant gender:

The primary purpose is to investigate the safety and efficacy of SPM927 in patients with Painful Diabetic Neuropathy

Phase 2

UCB Pharma

Lacosamide